Study to Evaluate an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Study Title

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.

Teva Identifier

PM014

ClinicalTrials.gov Identifier

NCT00240032

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

10/01/2004 - 07/01/2006

Phase

Phase 4

Study Type

Interventional